Brief: Clinical Evaluation Of Aptinyx's Nyx-783 For Treatment Of Opioid Use Disorder To Be Funded By $5.6 Million Nih Grant

Aptinyx

03/11/2022 11:36

Nov 3 (Reuters) - Aptinyx Inc  APTX.O :
    * CLINICAL EVALUATION OF APTINYX'S NYX-783 FOR TREATMENT OF
OPIOID
USE DISORDER TO BE FUNDED BY $5.6 MILLION NIH GRANT
    * APTINYX INC - PHASE 1 CLINICAL STUDY IN INDIVIDUALS USING
OPIOIDS EXPECTED TO BEGIN LATER THIS YEAR
    * APTINYX INC - NIH HEAL INITIATIVE GRANT, ADMINISTERED BY
NIDA,
FUNDS PRECLINICAL AND CLINICAL STUDIES OF NYX-783 IN OPIOID USE
DISORDER

Source text for Eikon:  ID:nBw3pksfna 
Further company coverage:  APTX.O 
 ((Reuters.Briefs@thomsonreuters.com;;))